Cargando…

A novel cell-free mitochondrial fusion assay amenable for high-throughput screenings of fusion modulators

BACKGROUND: Mitochondria are highly dynamic organelles whose morphology and position within the cell is tightly coupled to metabolic function. There is a limited list of essential proteins that regulate mitochondrial morphology and the mechanisms that govern mitochondrial dynamics are poorly underst...

Descripción completa

Detalles Bibliográficos
Autores principales: Schauss, Astrid C, Huang, Huiyan, Choi, Seok-Yong, Xu, Liqun, Soubeyrand, Sébastien, Bilodeau, Patricia, Zunino, Rodolfo, Rippstein, Peter, Frohman, Michael A, McBride, Heidi M
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2919466/
https://www.ncbi.nlm.nih.gov/pubmed/20659315
http://dx.doi.org/10.1186/1741-7007-8-100
_version_ 1782185188559683584
author Schauss, Astrid C
Huang, Huiyan
Choi, Seok-Yong
Xu, Liqun
Soubeyrand, Sébastien
Bilodeau, Patricia
Zunino, Rodolfo
Rippstein, Peter
Frohman, Michael A
McBride, Heidi M
author_facet Schauss, Astrid C
Huang, Huiyan
Choi, Seok-Yong
Xu, Liqun
Soubeyrand, Sébastien
Bilodeau, Patricia
Zunino, Rodolfo
Rippstein, Peter
Frohman, Michael A
McBride, Heidi M
author_sort Schauss, Astrid C
collection PubMed
description BACKGROUND: Mitochondria are highly dynamic organelles whose morphology and position within the cell is tightly coupled to metabolic function. There is a limited list of essential proteins that regulate mitochondrial morphology and the mechanisms that govern mitochondrial dynamics are poorly understood. However, recent evidence indicates that the core machinery that governs mitochondrial dynamics is linked within complex intracellular signalling cascades, including apoptotic pathways, cell cycle transitions and nuclear factor kappa B activation. Given the emerging importance of mitochondrial plasticity in cell signalling pathways and metabolism, it is essential that we develop tools to quantitatively analyse the processes of fission and fusion. In terms of mitochondrial fusion, the field currently relies upon on semi-quantitative assays which, even under optimal conditions, are labour-intensive, low-throughput and require complex imaging techniques. RESULTS: In order to overcome these technical limitations, we have developed a new, highly quantitative cell-free assay for mitochondrial fusion in mammalian cells. This assay system has allowed us to establish the energetic requirements for mitochondrial fusion. In addition, our data reveal a dependence on active protein phosphorylation for mitochondrial fusion, confirming emerging evidence that mitochondrial fusion is tightly integrated within the global cellular response to signaling events. Indeed, we have shown that cytosol derived from cells stimulated with different triggers either enhance or inhibit the cell-free fusion reaction. CONCLUSIONS: The adaptation of this system to high-throughput analysis will provide an unprecedented opportunity to identify and characterize novel regulatory factors. In addition, it provides a framework for a detailed mechanistic analysis of the process of mitochondrial fusion and the various axis of regulation that impinge upon this process in a wide range of cellular conditions. See Commentary: http://www.biomedcentral.com/1741-7007/8/99
format Text
id pubmed-2919466
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29194662010-08-11 A novel cell-free mitochondrial fusion assay amenable for high-throughput screenings of fusion modulators Schauss, Astrid C Huang, Huiyan Choi, Seok-Yong Xu, Liqun Soubeyrand, Sébastien Bilodeau, Patricia Zunino, Rodolfo Rippstein, Peter Frohman, Michael A McBride, Heidi M BMC Biol Methodology Article BACKGROUND: Mitochondria are highly dynamic organelles whose morphology and position within the cell is tightly coupled to metabolic function. There is a limited list of essential proteins that regulate mitochondrial morphology and the mechanisms that govern mitochondrial dynamics are poorly understood. However, recent evidence indicates that the core machinery that governs mitochondrial dynamics is linked within complex intracellular signalling cascades, including apoptotic pathways, cell cycle transitions and nuclear factor kappa B activation. Given the emerging importance of mitochondrial plasticity in cell signalling pathways and metabolism, it is essential that we develop tools to quantitatively analyse the processes of fission and fusion. In terms of mitochondrial fusion, the field currently relies upon on semi-quantitative assays which, even under optimal conditions, are labour-intensive, low-throughput and require complex imaging techniques. RESULTS: In order to overcome these technical limitations, we have developed a new, highly quantitative cell-free assay for mitochondrial fusion in mammalian cells. This assay system has allowed us to establish the energetic requirements for mitochondrial fusion. In addition, our data reveal a dependence on active protein phosphorylation for mitochondrial fusion, confirming emerging evidence that mitochondrial fusion is tightly integrated within the global cellular response to signaling events. Indeed, we have shown that cytosol derived from cells stimulated with different triggers either enhance or inhibit the cell-free fusion reaction. CONCLUSIONS: The adaptation of this system to high-throughput analysis will provide an unprecedented opportunity to identify and characterize novel regulatory factors. In addition, it provides a framework for a detailed mechanistic analysis of the process of mitochondrial fusion and the various axis of regulation that impinge upon this process in a wide range of cellular conditions. See Commentary: http://www.biomedcentral.com/1741-7007/8/99 BioMed Central 2010-07-26 /pmc/articles/PMC2919466/ /pubmed/20659315 http://dx.doi.org/10.1186/1741-7007-8-100 Text en Copyright ©2010 Schauss et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Methodology Article
Schauss, Astrid C
Huang, Huiyan
Choi, Seok-Yong
Xu, Liqun
Soubeyrand, Sébastien
Bilodeau, Patricia
Zunino, Rodolfo
Rippstein, Peter
Frohman, Michael A
McBride, Heidi M
A novel cell-free mitochondrial fusion assay amenable for high-throughput screenings of fusion modulators
title A novel cell-free mitochondrial fusion assay amenable for high-throughput screenings of fusion modulators
title_full A novel cell-free mitochondrial fusion assay amenable for high-throughput screenings of fusion modulators
title_fullStr A novel cell-free mitochondrial fusion assay amenable for high-throughput screenings of fusion modulators
title_full_unstemmed A novel cell-free mitochondrial fusion assay amenable for high-throughput screenings of fusion modulators
title_short A novel cell-free mitochondrial fusion assay amenable for high-throughput screenings of fusion modulators
title_sort novel cell-free mitochondrial fusion assay amenable for high-throughput screenings of fusion modulators
topic Methodology Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2919466/
https://www.ncbi.nlm.nih.gov/pubmed/20659315
http://dx.doi.org/10.1186/1741-7007-8-100
work_keys_str_mv AT schaussastridc anovelcellfreemitochondrialfusionassayamenableforhighthroughputscreeningsoffusionmodulators
AT huanghuiyan anovelcellfreemitochondrialfusionassayamenableforhighthroughputscreeningsoffusionmodulators
AT choiseokyong anovelcellfreemitochondrialfusionassayamenableforhighthroughputscreeningsoffusionmodulators
AT xuliqun anovelcellfreemitochondrialfusionassayamenableforhighthroughputscreeningsoffusionmodulators
AT soubeyrandsebastien anovelcellfreemitochondrialfusionassayamenableforhighthroughputscreeningsoffusionmodulators
AT bilodeaupatricia anovelcellfreemitochondrialfusionassayamenableforhighthroughputscreeningsoffusionmodulators
AT zuninorodolfo anovelcellfreemitochondrialfusionassayamenableforhighthroughputscreeningsoffusionmodulators
AT rippsteinpeter anovelcellfreemitochondrialfusionassayamenableforhighthroughputscreeningsoffusionmodulators
AT frohmanmichaela anovelcellfreemitochondrialfusionassayamenableforhighthroughputscreeningsoffusionmodulators
AT mcbrideheidim anovelcellfreemitochondrialfusionassayamenableforhighthroughputscreeningsoffusionmodulators
AT schaussastridc novelcellfreemitochondrialfusionassayamenableforhighthroughputscreeningsoffusionmodulators
AT huanghuiyan novelcellfreemitochondrialfusionassayamenableforhighthroughputscreeningsoffusionmodulators
AT choiseokyong novelcellfreemitochondrialfusionassayamenableforhighthroughputscreeningsoffusionmodulators
AT xuliqun novelcellfreemitochondrialfusionassayamenableforhighthroughputscreeningsoffusionmodulators
AT soubeyrandsebastien novelcellfreemitochondrialfusionassayamenableforhighthroughputscreeningsoffusionmodulators
AT bilodeaupatricia novelcellfreemitochondrialfusionassayamenableforhighthroughputscreeningsoffusionmodulators
AT zuninorodolfo novelcellfreemitochondrialfusionassayamenableforhighthroughputscreeningsoffusionmodulators
AT rippsteinpeter novelcellfreemitochondrialfusionassayamenableforhighthroughputscreeningsoffusionmodulators
AT frohmanmichaela novelcellfreemitochondrialfusionassayamenableforhighthroughputscreeningsoffusionmodulators
AT mcbrideheidim novelcellfreemitochondrialfusionassayamenableforhighthroughputscreeningsoffusionmodulators